解放军医药杂志
解放軍醫藥雜誌
해방군의약잡지
MEDICAL&PHARMACEUTICAL JOURNAL OF CHINESE PEOPLE'S LIBERATION ARMY
2015年
8期
72-74
,共3页
泪囊炎%泪囊鼻腔吻合术%自然腔道内镜手术%治疗结果%对比研究
淚囊炎%淚囊鼻腔吻閤術%自然腔道內鏡手術%治療結果%對比研究
루낭염%루낭비강문합술%자연강도내경수술%치료결과%대비연구
Dacryocystitis%Dacryocystorhinostomy%Natural orifice endoscopic surgery%Treatment outcome%Comparative study
目的:对比观察外路鼻腔泪囊吻合术与鼻内窥镜下鼻腔泪囊吻合术治疗慢性泪囊炎的临床效果。方法选择解放军252医院2011年9月—2013年9月收治的慢性泪囊炎120例(130眼),随机分为对照组(采取外路鼻腔泪囊吻合术)和观察组(采取鼻内窥镜下鼻腔泪囊吻合术),每组60例(65眼)。随访12个月,观察比较两组疗效和术后并发症发生情况。结果两组疗效比较差异无统计学意义( P>0.05);观察组术后并发症发生率显著低于对照组;两组均无复发病例。结论鼻内窥镜下鼻腔泪囊吻合术治疗慢性泪囊炎安全、有效、预后佳,患者满意度高。
目的:對比觀察外路鼻腔淚囊吻閤術與鼻內窺鏡下鼻腔淚囊吻閤術治療慢性淚囊炎的臨床效果。方法選擇解放軍252醫院2011年9月—2013年9月收治的慢性淚囊炎120例(130眼),隨機分為對照組(採取外路鼻腔淚囊吻閤術)和觀察組(採取鼻內窺鏡下鼻腔淚囊吻閤術),每組60例(65眼)。隨訪12箇月,觀察比較兩組療效和術後併髮癥髮生情況。結果兩組療效比較差異無統計學意義( P>0.05);觀察組術後併髮癥髮生率顯著低于對照組;兩組均無複髮病例。結論鼻內窺鏡下鼻腔淚囊吻閤術治療慢性淚囊炎安全、有效、預後佳,患者滿意度高。
목적:대비관찰외로비강루낭문합술여비내규경하비강루낭문합술치료만성루낭염적림상효과。방법선택해방군252의원2011년9월—2013년9월수치적만성루낭염120례(130안),수궤분위대조조(채취외로비강루낭문합술)화관찰조(채취비내규경하비강루낭문합술),매조60례(65안)。수방12개월,관찰비교량조료효화술후병발증발생정황。결과량조료효비교차이무통계학의의( P>0.05);관찰조술후병발증발생솔현저저우대조조;량조균무복발병례。결론비내규경하비강루낭문합술치료만성루낭염안전、유효、예후가,환자만의도고。
Objective To compare the effect between the external dacryocystorhinostomy and endoscopic dacryo-cystorhinostomy in treatment of chronic dacryocystitis. Methods A total of 120 patients (130 eyes) with chronic dacryo-cystitis admitted during September 2011 and September 2013 were randomly divided into control group undertaking exter-nal dacryocystorhinostomy ( n=60 patients, 65 eyes) and observation group undertaking endoscopic dacryocystorhinosto-my ( n=60 patients, 65 eyes) . The effect and incidence rate of postoperative complications in the two groups were ob-served and compared with a 12-month-follow-up. Results There was no significant difference in effect in the two groups (P>0. 05);the incidence rate of postoperative complications in the observation group was significantly lower than that in the control group. There was no recurrence in the two groups. Conclusion Endoscopic dacryocystorhinostomy in treat-ment of chronic dacryocystitis is safe and effective with good prognosis.